For Apollo, the Bayer deal is the latest in a series of private capital financings the New York-listed asset manager has struck with blue-chip companies. Over the years, the firm has spearheaded some of the industry’s most complex multibillion-dollar transactions, striking deals with corporates including Intel Corp., Electricité de France SA, and Vonovia SE.